Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.0750
-0.0130 (-14.77%)
At close: May 26, 2026
Hepion Pharmaceuticals Market Cap
Hepion Pharmaceuticals has a market cap or net worth of $2.18 million as of May 27, 2026. Its market cap has decreased by -30.94% in one year.
Market Cap
2.18M
Enterprise Value
1.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since February 10, 2014, Hepion Pharmaceuticals's market cap has decreased from 13.86M to 2.18M, a decrease of -84.24%. That is a compound annual growth rate of -13.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 2.18M | 213.24% |
| Dec 31, 2025 | 697.22K | -78.69% |
| Dec 31, 2024 | 3.27M | -76.72% |
| Dec 29, 2023 | 14.05M | -38.61% |
| Dec 30, 2022 | 22.89M | -73.66% |
| Dec 31, 2021 | 86.90M | 23.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adaptimmune Therapeutics | 3.18M |
| Eastgate Biotech | 3.17M |
| Iterum Therapeutics | 2.91M |
| LakeShore Biopharma | 2.88M |
| ProtoKinetix | 2.74M |
| Eloxx Pharmaceuticals | 2.73M |
| Vaccinex | 2.68M |
| Enzolytics | 2.42M |